Reliable in vitro studies require appropriate ovarian cancer cell lines

Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma

(2013) Niloofar N. Nik et al.   Annual Review of Pathology-Mechanisms of Disease

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

(2013) Ruth Perets et al.   CANCER CELL

Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions

(2013) G. Chene et al.   CLINICAL CANCER RESEARCH

Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?

(2013) Nelly Auersperg   GYNECOLOGIC ONCOLOGY

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

(2013) Eleftherios Samartzis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hiding in Plain View: Genetic Profiling Reveals Decades Old Cross Contamination of Bladder Cancer Cell Line KU7 with HeLa

(2013) Wolfgang Jäger et al.   JOURNAL OF UROLOGY

Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche

(2013) Andrea Flesken-Nikitin et al.   NATURE

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

(2013) Michael S. Anglesio et al.   PLoS One

Gene Expression Signature of Normal Cell-of-Origin Predicts Ovarian Tumor Outcomes

(2013) Melissa A. Merritt et al.   PLoS One

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

(2012) Christopher Korch et al.   GYNECOLOGIC ONCOLOGY

Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma

(2012) Elisabetta Kuhn et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

(2011) Kate M. Im et al.   HUMAN GENETICS

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions

(2011) Elisabetta Kuhn et al.   JOURNAL OF PATHOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

“Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer

(2010) Jeffrey D. Seidman et al.   GYNECOLOGIC ONCOLOGY

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004

(2009) M. T. Goodman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Serous Carcinogenesis in the Fallopian Tube

(2009) Elke Jarboe et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Intercepting pelvic cancer in the distal fallopian tube: Theories and realities

(2009) Christopher P. Crum   Molecular Oncology

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma

(2008) Shannon Salvador et al.   GYNECOLOGIC ONCOLOGY

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

(2008) Charles N. Landen et al.   JOURNAL OF CLINICAL ONCOLOGY

The cell of origin of ovarian epithelial tumours

(2008) Louis Dubeau   LANCET ONCOLOGY